Peripheral (E)-2-(4-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one)-coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors

In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the effic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archiv der Pharmazie (Weinheim) 2024-09, Vol.357 (9), p.e2400209
Hauptverfasser: Güleç, Özcan, Bilgiçli, Ahmet T, Tüzün, Burak, Taslimi, Parham, Günsel, Armağan, Gülçin, İlhami, Arslan, Mustafa, Yarasir, M Nilüfer
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 9
container_start_page e2400209
container_title Archiv der Pharmazie (Weinheim)
container_volume 357
creator Güleç, Özcan
Bilgiçli, Ahmet T
Tüzün, Burak
Taslimi, Parham
Günsel, Armağan
Gülçin, İlhami
Arslan, Mustafa
Yarasir, M Nilüfer
description In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein that is the crystal structure of hCA I (PDB ID: 2CAB), the crystal structure of hCA II (PDB ID: 5AML), and the crystal structure of α-Gly (PDB ID: 1R47), were examined. Following that, Protein-Ligand Interaction Profiler (PLIP) analysis was used to look at the interactions that occurred during the docking calculation in further detail.In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein t
doi_str_mv 10.1002/ardp.202400209
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_3065275320</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3065275320</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_30652753203</originalsourceid><addsrcrecordid>eNqVjj1PBCEQhonRxPOjtabcTeQEdteP2py50sL-wsIYxrCAwJ2uP8tfKKcWtlYzk-eZNy8hF4IvBefySiUTl5LLvh787oAsxCAF68Vtf_hnPyYnOb9wzjsuhwX5fISE0UJSjjarlknW9MzOJoX3eQT_MTs04KFl3WXPDH4Tr6ItVjnwTDRy3bKwF3QIyaBXBQz94UHPyqOHTN-wWIpTTGFX6T52Aore4ogFg6cVREgFq6r8_j2UEO2cUQdtYUJd241g1Q5Dymfk6Fm5DOe_85Q0D6un-zWrKa9byGUzYdbgnPIQtnnT8etB3gyd5N0_1C_jKG4M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3065275320</pqid></control><display><type>article</type><title>Peripheral (E)-2-(4-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one)-coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Güleç, Özcan ; Bilgiçli, Ahmet T ; Tüzün, Burak ; Taslimi, Parham ; Günsel, Armağan ; Gülçin, İlhami ; Arslan, Mustafa ; Yarasir, M Nilüfer</creator><creatorcontrib>Güleç, Özcan ; Bilgiçli, Ahmet T ; Tüzün, Burak ; Taslimi, Parham ; Günsel, Armağan ; Gülçin, İlhami ; Arslan, Mustafa ; Yarasir, M Nilüfer</creatorcontrib><description>In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein that is the crystal structure of hCA I (PDB ID: 2CAB), the crystal structure of hCA II (PDB ID: 5AML), and the crystal structure of α-Gly (PDB ID: 1R47), were examined. Following that, Protein-Ligand Interaction Profiler (PLIP) analysis was used to look at the interactions that occurred during the docking calculation in further detail.In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein that is the crystal structure of hCA I (PDB ID: 2CAB), the crystal structure of hCA II (PDB ID: 5AML), and the crystal structure of α-Gly (PDB ID: 1R47), were examined. Following that, Protein-Ligand Interaction Profiler (PLIP) analysis was used to look at the interactions that occurred during the docking calculation in further detail.</description><identifier>ISSN: 1521-4184</identifier><identifier>EISSN: 1521-4184</identifier><identifier>DOI: 10.1002/ardp.202400209</identifier><language>eng</language><ispartof>Archiv der Pharmazie (Weinheim), 2024-09, Vol.357 (9), p.e2400209</ispartof><rights>2024 The Author(s). Archiv der Pharmazie published by Wiley‐VCH GmbH on behalf of Deutsche Pharmazeutische Gesellschaft.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Güleç, Özcan</creatorcontrib><creatorcontrib>Bilgiçli, Ahmet T</creatorcontrib><creatorcontrib>Tüzün, Burak</creatorcontrib><creatorcontrib>Taslimi, Parham</creatorcontrib><creatorcontrib>Günsel, Armağan</creatorcontrib><creatorcontrib>Gülçin, İlhami</creatorcontrib><creatorcontrib>Arslan, Mustafa</creatorcontrib><creatorcontrib>Yarasir, M Nilüfer</creatorcontrib><title>Peripheral (E)-2-(4-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one)-coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors</title><title>Archiv der Pharmazie (Weinheim)</title><description>In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein that is the crystal structure of hCA I (PDB ID: 2CAB), the crystal structure of hCA II (PDB ID: 5AML), and the crystal structure of α-Gly (PDB ID: 1R47), were examined. Following that, Protein-Ligand Interaction Profiler (PLIP) analysis was used to look at the interactions that occurred during the docking calculation in further detail.In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein that is the crystal structure of hCA I (PDB ID: 2CAB), the crystal structure of hCA II (PDB ID: 5AML), and the crystal structure of α-Gly (PDB ID: 1R47), were examined. Following that, Protein-Ligand Interaction Profiler (PLIP) analysis was used to look at the interactions that occurred during the docking calculation in further detail.</description><issn>1521-4184</issn><issn>1521-4184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVjj1PBCEQhonRxPOjtabcTeQEdteP2py50sL-wsIYxrCAwJ2uP8tfKKcWtlYzk-eZNy8hF4IvBefySiUTl5LLvh787oAsxCAF68Vtf_hnPyYnOb9wzjsuhwX5fISE0UJSjjarlknW9MzOJoX3eQT_MTs04KFl3WXPDH4Tr6ItVjnwTDRy3bKwF3QIyaBXBQz94UHPyqOHTN-wWIpTTGFX6T52Aore4ogFg6cVREgFq6r8_j2UEO2cUQdtYUJd241g1Q5Dymfk6Fm5DOe_85Q0D6un-zWrKa9byGUzYdbgnPIQtnnT8etB3gyd5N0_1C_jKG4M</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>Güleç, Özcan</creator><creator>Bilgiçli, Ahmet T</creator><creator>Tüzün, Burak</creator><creator>Taslimi, Parham</creator><creator>Günsel, Armağan</creator><creator>Gülçin, İlhami</creator><creator>Arslan, Mustafa</creator><creator>Yarasir, M Nilüfer</creator><scope>7X8</scope></search><sort><creationdate>20240901</creationdate><title>Peripheral (E)-2-(4-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one)-coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors</title><author>Güleç, Özcan ; Bilgiçli, Ahmet T ; Tüzün, Burak ; Taslimi, Parham ; Günsel, Armağan ; Gülçin, İlhami ; Arslan, Mustafa ; Yarasir, M Nilüfer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_30652753203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Güleç, Özcan</creatorcontrib><creatorcontrib>Bilgiçli, Ahmet T</creatorcontrib><creatorcontrib>Tüzün, Burak</creatorcontrib><creatorcontrib>Taslimi, Parham</creatorcontrib><creatorcontrib>Günsel, Armağan</creatorcontrib><creatorcontrib>Gülçin, İlhami</creatorcontrib><creatorcontrib>Arslan, Mustafa</creatorcontrib><creatorcontrib>Yarasir, M Nilüfer</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>Archiv der Pharmazie (Weinheim)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Güleç, Özcan</au><au>Bilgiçli, Ahmet T</au><au>Tüzün, Burak</au><au>Taslimi, Parham</au><au>Günsel, Armağan</au><au>Gülçin, İlhami</au><au>Arslan, Mustafa</au><au>Yarasir, M Nilüfer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral (E)-2-(4-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one)-coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors</atitle><jtitle>Archiv der Pharmazie (Weinheim)</jtitle><date>2024-09-01</date><risdate>2024</risdate><volume>357</volume><issue>9</issue><spage>e2400209</spage><pages>e2400209-</pages><issn>1521-4184</issn><eissn>1521-4184</eissn><abstract>In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein that is the crystal structure of hCA I (PDB ID: 2CAB), the crystal structure of hCA II (PDB ID: 5AML), and the crystal structure of α-Gly (PDB ID: 1R47), were examined. Following that, Protein-Ligand Interaction Profiler (PLIP) analysis was used to look at the interactions that occurred during the docking calculation in further detail.In this study, (E)-4-{4-[(1-oxo-3,4-dihydronaphthalen-2(1H)-ylidene)methyl]phenoxy}phthalonitrile (4) and its phthalocyanine derivatives (5-8) were synthesized for the first time. Aggregation behaviors of the novel soluble phthalocyanines in organic solvents were investigated. In addition, the efficiency of 1O2 production of (5) and ZnPc (6) was investigated. The singlet oxygen quantum yields (ΦΔ) for 2HPc (5) and ZnPc (6) were found to be 0.58 and 0.83, respectively. Additionally, novel phthalocyanines (5-8) were investigated for their ability to inhibit enzymes. They exhibited a highly potent inhibition effect on human carbonic anhydrase I and II (hCA I and II) and α-glycosidase (α-Gly) enzymes. Ki values are in the range of 2.60 ± 9.87 to 11.53 ± 6.92 µM, 3.35 ± 0.53 to 15.47 ± 1.20 µM, and 28.60 ± 4.82 to 40.58 ± 7.37 nM, respectively. The calculations of the studied molecule at the B3LYP, HF, and M062X levels in the 6-31G basis sets were made using the Gaussian package program. Afterward, the interactions occurring in the docking calculation against a protein that is the crystal structure of hCA I (PDB ID: 2CAB), the crystal structure of hCA II (PDB ID: 5AML), and the crystal structure of α-Gly (PDB ID: 1R47), were examined. Following that, Protein-Ligand Interaction Profiler (PLIP) analysis was used to look at the interactions that occurred during the docking calculation in further detail.</abstract><doi>10.1002/ardp.202400209</doi></addata></record>
fulltext fulltext
identifier ISSN: 1521-4184
ispartof Archiv der Pharmazie (Weinheim), 2024-09, Vol.357 (9), p.e2400209
issn 1521-4184
1521-4184
language eng
recordid cdi_proquest_miscellaneous_3065275320
source Wiley Online Library Journals Frontfile Complete
title Peripheral (E)-2-(4-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one)-coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A24%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20(E)-2-(4-hydroxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one)-coordinated%20phthalocyanines%20with%20improved%20enzyme%20inhibition%20properties%20and%20photophysicochemical%20behaviors&rft.jtitle=Archiv%20der%20Pharmazie%20(Weinheim)&rft.au=G%C3%BCle%C3%A7,%20%C3%96zcan&rft.date=2024-09-01&rft.volume=357&rft.issue=9&rft.spage=e2400209&rft.pages=e2400209-&rft.issn=1521-4184&rft.eissn=1521-4184&rft_id=info:doi/10.1002/ardp.202400209&rft_dat=%3Cproquest%3E3065275320%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3065275320&rft_id=info:pmid/&rfr_iscdi=true